I'm LongbridgeAI, I can summarize articles.Kush Parmar, a director and 10% owner of Entrada Therapeutics, sold $807,529 worth of common shares on July 30-31. The transaction involved selling 116,474 shares at weighted average prices between $6.85 and $6.93. This sale reduced 5AM Ventures V’s stake to 2,846,592 shares, while 5AM Opportunities I retained 1,093,313 shares.
- Entrada Therapeutics director Kush Parmar reported sales of 116,474 shares on July 30-31, cutting 5AM Ventures V’s stake to 2,846,592 shares. * The July 30 sale covered 114,756 shares at a weighted average price of $6.93. * The July 31 sale covered 1,718 shares at $6.85. * 5AM Opportunities I held 1,093,313 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001664281-26-000002), on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here